Home LiteratureArticle Details
PMID: 20160028 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

An oncogenic role for ETV1 in melanoma.

Cancer research ·Vol. 70 ·No. 5 ·2010-03-01 ·Pages 2075-84

Jané-Valbuena J, Widlund HR, Perner S, Johnson LA, Dibner AC, Lin WM, Baker AC, Nazarian RM, Vijayendran KG, Sellers WR, Hahn WC, Duncan LM, Rubin MA, Fisher DE, Garraway LA

Abstract

Copy gains involving chromosome 7p represent one of the most common genomic alterations found in melanomas, suggesting the presence of "driver" cancer genes. We identified several tumor samples that harbored focal amplifications situated at the peak of common chromosome 7p gains, in which the minimal common overlapping region spanned the ETV1 oncogene. Fluorescence in situ hybridization analysis revealed copy gains spanning the ETV1 locus in >40% of cases, with ETV1 amplification (>6 copies/cell) present in 13% of primary and 18% of metastatic melanomas. Melanoma cell lines, including those with ETV1 amplification, exhibited dependency on ETV1 expression for proliferation and anchorage-independent growth. Moreover, overexpression of ETV1 in combination with oncogenic NRAS(G12D) transformed primary melanocytes and promoted tumor formation in mice. ETV1 overexpression elevated microphthalmia-associated transcription factor expression in immortalized melanocytes, which was necessary for ETV1-dependent oncogenicity. These observations implicate deregulated ETV1 in melanoma genesis and suggest a pivotal lineage dependency mediated by oncogenic ETS transcription factors in this malignancy.

MeSH Terms
Animals Cell Transformation, Neoplastic/genetics,metabolism DNA-Binding Proteins/biosynthesis,genetics Female Gene Amplification Genes, ras Humans Melanoma/genetics,metabolism Mice Mice, Nude Microphthalmia-Associated Transcription Factor/biosynthesis,genetics Oligonucleotide Array Sequence Analysis Oncogenes Polymorphism, Single Nucleotide Proto-Oncogene Proteins B-raf/genetics Transcription Factors/biosynthesis,genetics Transplantation, Heterologous Up-Regulation
Chemicals
DNA-Binding Proteins ETV1 protein, human MITF protein, human Microphthalmia-Associated Transcription Factor Transcription Factors BRAF protein, human Proto-Oncogene Proteins B-raf
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Jané-Valbuena Judit
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Widlund Hans R
Perner Sven
Johnson Laura A
Dibner Aurora C
Lin William M
Baker Alissa C
Nazarian Rosalynn M
Vijayendran Krishna G
Sellers William R
Hahn William C
Duncan Lyn M
Rubin Mark A
Fisher David E
Garraway Levi A
References (28)
28 references, click to expand
  1. EML4-ALK fusion lung cancer: a rare acquired event.
    Neoplasia. 2008 Mar;10(3):298-302 PMID: 18320074
  2. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.
    Nat Genet. 2009 May;41(5):524-6 PMID: 19396167
  3. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Cancer Res. 2009 Oct 15;69(20):8102-10 PMID: 19789348
  4. Ets proteins in biological control and cancer.
    J Cell Biochem. 2004 Apr 1;91(5):896-903 PMID: 15034925
  5. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
    Mol Cell Biol. 2004 Jan;24(1):25-35 PMID: 14673140
  6. High-throughput oncogene mutation profiling in human cancer.
    Nat Genet. 2007 Mar;39(3):347-51 PMID: 17293865
  7. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
    Cancer Res. 2008 Sep 15;68(18):7541-9 PMID: 18794142
  8. Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.
    Transgenic Res. 2002 Apr;11(2):123-31 PMID: 12054346
  9. Analysis of the ERK-stimulated ETS transcription factor ER81.
    Mol Cell Biol. 1996 Apr;16(4):1550-6 PMID: 8657129
  10. (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway.
    Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4519-24 PMID: 19251651
  11. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Oncogene. 1995 Sep 21;11(6):1049-54 PMID: 7566963
  12. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Nature. 2007 Aug 2;448(7153):595-9 PMID: 17671502
  13. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.
    Cell. 2006 Jun 30;125(7):1269-81 PMID: 16814714
  14. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.
    Nature. 1983 Nov 24-30;306(5941):395-7 PMID: 6316156
  15. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
    Nat Genet. 2009 May;41(5):619-24 PMID: 19396168
  16. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
    Cancer Res. 1998 May 15;58(10):2170-5 PMID: 9605762
  17. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.
    Oncogene. 2001 Sep 27;20(43):6215-24 PMID: 11593430
  18. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
    Br J Dermatol. 1994 Jul;131(1):72-7 PMID: 8043423
  19. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
    Oncogene. 1995 Mar 16;10(6):1229-34 PMID: 7700648
  20. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
    Mol Cell Biol. 1994 May;14(5):3230-41 PMID: 8164678
  21. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.
    Nature. 1998 Jan 15;391(6664):298-301 PMID: 9440696
  22. Modeling genomic diversity and tumor dependency in malignant melanoma.
    Cancer Res. 2008 Feb 1;68(3):664-73 PMID: 18245465
  23. Mutations of the BRAF gene in human cancer.
    Nature. 2002 Jun 27;417(6892):949-54 PMID: 12068308
  24. Distinct sets of genetic alterations in melanoma.
    N Engl J Med. 2005 Nov 17;353(20):2135-47 PMID: 16291983
  25. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
    Int J Cancer. 1997 Mar 4;70(5):590-7 PMID: 9052761
  26. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Nature. 2005 Jul 7;436(7047):117-22 PMID: 16001072
  27. Molecular biology of the Ets family of transcription factors.
    Gene. 2003 Jan 16;303:11-34 PMID: 12559563
  28. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
    Science. 2005 Oct 28;310(5748):644-8 PMID: 16254181
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2010-03-01
Epub
2010-00-16
Pages
2075-84
Language
English
Region
United States
NLM ID
2984705R
PMCID
PMC2846410
Subset
IM
Grants
NIH HHS · DP2 OD002750 · United States
NIH HHS · DP2 OD002750-01 · United States
NIAMS NIH HHS · R01 AR043369 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]